HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Primary hyperparathyroidism--diagnostic problems].

Abstract
Parathyroid imaging with 99m Tc-MIBI, introduced at the beginning of the 90's seems to be a promising method for parathyroid adenomas localization. The aim of the study was to assess the efficacy of parathyroid imaging with 99m Tc-MIBI for preoperative localization of parathyroid adenomas and to compare that method with the high-resolution ultrasonography. Thirteen patients with primary hyperparathyroidism of duration from 2 to 25 years were included in the study. The presence of parathyroid adenomas was confirmed by histopathology in all patients. The sensitivity for scintigraphy and ultrasonography was 92.8% and 78.5%, the number of false positive results was 0 and 2 and false negative-0 and 1, respectively. Parathyroid imaging with 99m Tc-MIBI is a useful method for parathyroid adenomas localization, and in contrast to ultrasonography its sensitivity does not decrease if a parathyroid adenoma is located ectopically. Nevertheless, because of the greater accessibility, lower costs and its simplicity ultrasonography should be used as a screening modality for parathyroid adenoma localization.
AuthorsW Horst-Sikorska, D Baszko-Błaszczyk, M Drews, R Junik, L Pietz, M Gembicki, J Kosowicz
JournalPolskie Archiwum Medycyny Wewnetrznej (Pol Arch Med Wewn) Vol. 95 Issue 6 Pg. 534-41 (Jun 1996) Poland
Vernacular TitlePierwotna nadczynność przytarczyc--problemy diagnostyczne.
PMID9005422 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article)
Chemical References
  • Technetium Tc 99m Sestamibi
Topics
  • Adolescent
  • Adult
  • Aged
  • Female
  • Humans
  • Hyperparathyroidism (diagnostic imaging, prevention & control)
  • Male
  • Mass Screening (methods)
  • Middle Aged
  • Predictive Value of Tests
  • Radionuclide Imaging
  • Sensitivity and Specificity
  • Technetium Tc 99m Sestamibi
  • Ultrasonography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: